Single-Cell Proteomics for Immune Profiling in Cancer
Clinical Lab Manager | May 20, 2022
Proteomics assays provide insight into cancer disease and treatment response, allowing for potent and durable therapies
Using Collaboration to Address the Challenges Facing Lab Medicine
Join Clinical Lab Manager and Lona Small, MT (ASCP), MBA, PMP, CBPM to discuss the importance of collaboration in solving many challenges facing lab medicine and patient care today.
Using Collaboration to Address the Challenges Facing Lab Medicine
Using Collaboration to Address the Challenges Facing Lab Medicine
Join Clinical Lab Manager and Lona Small, MT (ASCP), MBA, PMP, CBPM to discuss the importance of collaboration in solving many challenges facing lab medicine and patient care today.
Join Clinical Lab Manager and Lona Small, MT (ASCP), MBA, PMP, CBPM to discuss the importance of collaboration in solving many challenges facing lab medicine and patient care today.
Latest
CDC Expands Eligibility for COVID-19 Booster Shots
Centers for Disease Control and Prevention | May 20, 2022
The CDC expands eligibility and strengthens recommendations for COVID-19 boosters
WHO Validates 11th Vaccine for COVID-19
World Health Organization | May 20, 2022
CONVIDECIA is based on a modified human adenovirus that expresses the spike S protein of SARS-CoV-2
Is Sudden Infant Death Linked to Cholinergic Dysfunction?
Zahraa Chorghay, PhD | May 20, 2022
A potential biomarker for SIDS offers hope but should be interpreted cautiously
Résumés for Clinical Professionals: A Unique Approach
Clinical Lab Manager | May 20, 2022
Join Clinical Lab Manager and Alison Foo, MSc, PMP, to learn how to write your résumé to make the best first impression to your potential employer.
Depression Associated with Increased Hospitalization Risk after COVID-19
National Institutes of Health | May 19, 2022
Findings suggest that psychological risk factors may increase hospitalization risk
Why Do Cancer Drugs Lead to Immune-Related Adverse Effects?
Zahraa Chorghay, PhD | May 19, 2022
Side effects of PI3Kδ immunotherapy could be mitigated by changing drug dosing
Industry Lobbying on WHO Overshadowing Public Health Policy
University of California, Davis | May 19, 2022
Corporate dollars elevate commercial interests over health expertise
Eligibility for Pfizer-BioNTech COVID-19 Vaccine Booster Dose Expanded
U.S. Food and Drug Administration | May 18, 2022
The FDA expanded the eligibility for the vaccine booster dose to individuals five through 11 years of age
Guidelines Ensure Assessment of Patient Symptoms, Quality of Life Is Ethical
University of Birmingham | May 18, 2022
Ethical guidelines in clinical research can reduce risk, increase participation, protect the welfare of participants